NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/06/2022
Back to search
Official data from USPTO
FEMTOBIOMED ONCO-LAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
FEMTOBIOMED ONCO-LAB
ST13
US500000090260698Class
9, 10
Filing
90260698
Registration
6915157
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/06/2022
Classification
Registered
Trademark type
Word
Nice classes
9, 10
Filing date
10/16/2020
Registration date
12/06/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/06/2022
Last transaction
12/06/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Seongnam-si,Gyeonggido, KR
Examiner
CHANG, KATHERINE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
FEMTOBIOMED Inc.
Representatives
James R Menker HOLLEY & MENKER, PA
Technical classification
Nice Classes
Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
DNA chips; downloadable computer software for measuring and analyzing interfacial energy; interfacial energy measuring and analyzing apparatus in the nature of force measurement productsdigital force gaugesdigital torque gauges and manual and motorized test stands used therewith sold as a unit with the gaugestension testers; optical profilers; data processing apparatus in the nature of digitizers being measuring instrumentation and apparatus; digital measuring apparatus in the nature of digital multimeters; laboratory equipment and suppliesincubators for cell culture; bioreactor for cell culturing; cell measuring apparatus in the nature of electronic apparatus for electrophysiological measurement of cells; free fatty acid measuring and analyzing apparatus for laboratory use being research laboratory analyzers for measuring and analyzing blood and other bodily fluids; intracellular material injector for laboratory use in the nature of injection instrument with needlesneedle-based and needle-free injection systems; downloadable computer software for measuring and analyzing free fatty acid; gene analyzing and extracting deviceslaboratory apparatus and instruments for extracting DNA; laboratory apparatus and instrumentsgene amplifiers in the nature of DNA microarrays; downloadable computer software for diagnosing diseases for medical purposes; measuring deviceselectricelectronic apparatus for electrophysiological measurement of cells; downloadable computer software for measuring and analyzing contact angle; contact angle measuring and analyzing apparatusangle finders; precision measuring apparatuslaboratory equipment and suppliescalipers; surveying instruments
Class 10
Apparatus for use in medical analysismedical diagnostic apparatus for testing DNA and RNA samples; diagnostic apparatus for medical purposes for testing blood sugar levelscancer cellsDNA; diabetes measuring apparatus being blood glucose meter; medical immunoassay apparatusimmunochemical testing apparatus for medical use; immunoassay apparatus for diagnostic in the nature of medical diagnostic apparatus for detecting cancermedical diagnostic apparatus for testing DNA and RNA samples; cell culture instruments for medical usecell culture chambers; free fatty acid measuring device being medical instruments; measuring instruments for medical purposes for measuring and displaying cancer cellsDNAblood cells and extra cellular contents; cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cellsDNAblood cells and extra cellular contents; intracellular material injector for medical purposes in the nature of injection instrument with needlesneedle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signsfor use in orthopedic surgery; apparatus for analysing substances for medical purposesblood and cell analyzers for medical diagnostics; test tubes for cell separation for medical purposes in the nature of blood testing apparatusblood sampling tubes; apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; blood testing apparatus; infusion apparatus for therapeutic purposesmedical apparatusinfusion devices for administering drugs
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/20/2022
PUBO
PUBLISHED FOR OPPOSITION
09/20/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/31/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/15/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2022
ALIE
ASSIGNED TO LIE
07/08/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/23/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/21/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/21/2022
CNSI
SUSPENSION INQUIRY WRITTEN
01/21/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/21/2021
GNSL
LETTER OF SUSPENSION E-MAILED
07/21/2021
CNSL
SUSPENSION LETTER WRITTEN
07/21/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/28/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/28/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/28/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/17/2021
GNRT
NON-FINAL ACTION E-MAILED
03/17/2021
CNRT
NON-FINAL ACTION WRITTEN
03/17/2021
DOCK
ASSIGNED TO EXAMINER
03/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2020
NWAP
NEW APPLICATION ENTERED
10/20/2020
Continuous trademark protection
Get notified about every new filing that threatens FEMTOBIOMED ONCO-LAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.